- Home
- ARBB vs PHIO Comparison
ARBB vs PHIO Comparison
Compare ARBB & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- PHIO
- Stock Information
- Founded
- ARBB 1997
- PHIO 2011
- Country
- ARBB Singapore
- PHIO United States
- Employees
- ARBB N/A
- PHIO N/A
- Industry
- ARBB EDP Services
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- ARBB Technology
- PHIO Health Care
- Exchange
- ARBB Nasdaq
- PHIO Nasdaq
- Market Cap
- ARBB 13.3M
- PHIO 12.1M
- IPO Year
- ARBB 2023
- PHIO N/A
- Fundamental
- Price
- ARBB $5.64
- PHIO $1.57
- Analyst Decision
- ARBB Strong Buy
- PHIO Strong Buy
- Analyst Count
- ARBB 1
- PHIO 3
- Target Price
- ARBB $20.00
- PHIO $10.67
- AVG Volume (30 Days)
- ARBB 218.7K
- PHIO 8.6M
- Earning Date
- ARBB 11-03-2025
- PHIO 11-11-2025
- Dividend Yield
- ARBB N/A
- PHIO N/A
- EPS Growth
- ARBB N/A
- PHIO N/A
- EPS
- ARBB N/A
- PHIO N/A
- Revenue
- ARBB $46,842,655.00
- PHIO N/A
- Revenue This Year
- ARBB N/A
- PHIO N/A
- Revenue Next Year
- ARBB $24.79
- PHIO N/A
- P/E Ratio
- ARBB N/A
- PHIO N/A
- Revenue Growth
- ARBB 239.12
- PHIO N/A
- 52 Week Low
- ARBB $3.92
- PHIO $0.97
- 52 Week High
- ARBB $18.60
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- ARBB 46.42
- PHIO 30.01
- Support Level
- ARBB $5.41
- PHIO $1.50
- Resistance Level
- ARBB $6.00
- PHIO $4.19
- Average True Range (ATR)
- ARBB 0.60
- PHIO 0.29
- MACD
- ARBB -0.02
- PHIO -0.04
- Stochastic Oscillator
- ARBB 18.15
- PHIO 7.75
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.